We are a research-based specialty
biopharma company determined
to give people worldwide a longer
and better life

We are developing the first vaccine
in the world for protection against
diarrhoea caused by ETEC in both
travellers and endemic populations

We distribute a wide range of
specialty biopharma products with
focus on vaccines and immunoglobulins

Scandinavian Biopharma

Welcome to Scandinavian Biopharma,

We are an entrepreneurial company specialised in global vaccine development, manufacturing, registration and commercialization of biopharmaceutical products. Our team has previously successfully developed, manufactured, registered and globally l[...]
Read more

Scandinavian Biopharma

Scandinavian Biopharma is once again looking back on a very successful business year

Scandinavian Biopharma can look back on a very successful 2019! The company was granted 10.6 MEUR from the EDCTP for a phase III trial of the ETEC vaccine candidate ETVAX¬ģ in children in Low- and Middle-Income Countries (LMIC). Impressive clini[...]
Read more

R&D

Scandinavian Biopharma

Welcome Morgan Hjorth

Scandinavian Biopharma continues to expand and strengthen the organization and we are happy to announce that Morgan Hjorth has joined our team. Morgan recently graduate from Karolinska Institute and Royal Institute of Technology (KTH) with two b[...]
Read more